ANO1 and prostate carcinoma: Regarding the relationship between TGF-β and TMEM16A, Atala et al. reported that the knockdown of TMEM16A decreased ICl,Ca, impaired TGF-β secretion, reduced E-cadherin expression, and inhibited migration and invasion without affecting the proliferation of prostate cancer cells [37].